Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Non-controlling interests
Beginning balance (in shares) at Dec. 31, 2022   90,837,000        
Beginning balance at Dec. 31, 2022 $ 1,664,746 $ 908 $ 1,924,200 $ (285,474) $ (10,397) $ 35,509
Ending balance (in shares) at Mar. 31, 2023   91,658,000        
Ending balance at Mar. 31, 2023 1,658,815 $ 917 1,946,904 (297,708) (32,820) 41,522
Beginning balance (in shares) at Dec. 31, 2022   90,837,000        
Beginning balance at Dec. 31, 2022 1,664,746 $ 908 1,924,200 (285,474) (10,397) 35,509
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 38,120     37,628   492
Unrealized gain (loss) on available-for-sale securities and securitization assets 3,568       3,521 47
Unrealized gain (loss) on interest rate swaps (1,116)       (1,127) 11
Issued shares of common stock (in shares)   15,867,000        
Issued shares of common stock 358,973 $ 159 358,814      
Equity-based compensation 11,478   1,675     9,803
Issuance (repurchase) of vested equity-based compensation shares (in shares)   66,000        
Issuance (repurchase) of vested equity-based compensation shares (1,435) $ 1 (1,436)      
Conversion of Convertible Notes 2   2      
Dividends and distributions (80,431)     (78,567)   (1,864)
Ending balance (in shares) at Jun. 30, 2023   106,770,000        
Ending balance at Jun. 30, 2023 1,993,905 $ 1,068 2,283,255 (326,413) (8,003) 43,998
Beginning balance (in shares) at Mar. 31, 2023   91,658,000        
Beginning balance at Mar. 31, 2023 1,658,815 $ 917 1,946,904 (297,708) (32,820) 41,522
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 13,522     13,522    
Unrealized gain (loss) on available-for-sale securities and securitization assets (5,308)       (5,238) (70)
Unrealized gain (loss) on interest rate swaps 30,651       30,055 596
Issued shares of common stock (in shares)   15,104,000        
Issued shares of common stock 335,717 $ 151 335,566      
Equity-based compensation 3,580   901     2,679
Issuance (repurchase) of vested equity-based compensation shares (in shares)   8,000        
Issuance (repurchase) of vested equity-based compensation shares (118)   (118)      
Conversion of Convertible Notes 2   2      
Dividends and distributions (42,956)     (42,227)   (729)
Ending balance (in shares) at Jun. 30, 2023   106,770,000        
Ending balance at Jun. 30, 2023 $ 1,993,905 $ 1,068 2,283,255 (326,413) (8,003) 43,998
Beginning balance (in shares) at Dec. 31, 2023 112,174,279 112,174,000        
Beginning balance at Dec. 31, 2023 $ 2,141,625 $ 1,122 2,381,510 (303,536) 13,165 49,364
Ending balance (in shares) at Mar. 31, 2024   113,476,000        
Ending balance at Mar. 31, 2024 $ 2,273,415 $ 1,135 2,415,118 (227,820) 29,111 55,871
Beginning balance (in shares) at Dec. 31, 2023 112,174,279 112,174,000        
Beginning balance at Dec. 31, 2023 $ 2,141,625 $ 1,122 2,381,510 (303,536) 13,165 49,364
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 151,492     149,566   1,926
Unrealized gain (loss) on available-for-sale securities and securitization assets (9,650)       (9,527) (123)
Unrealized gain (loss) on interest rate swaps 37,896       37,414 482
Issued shares of common stock (in shares)   2,956,000        
Issued shares of common stock 84,471 $ 30 84,441      
Equity-based compensation 14,883   2,027     12,856
Issuance (repurchase) of vested equity-based compensation shares (in shares)   22,000        
Issuance (repurchase) of vested equity-based compensation shares (466)   (466)      
Dividends and distributions $ (97,084)     (95,307)   (1,777)
Ending balance (in shares) at Jun. 30, 2024 115,151,661 115,152,000        
Ending balance at Jun. 30, 2024 $ 2,323,167 $ 1,152 2,467,512 (249,277) 41,052 62,728
Beginning balance (in shares) at Mar. 31, 2024   113,476,000        
Beginning balance at Mar. 31, 2024 2,273,415 $ 1,135 2,415,118 (227,820) 29,111 55,871
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 26,944     26,541   403
Unrealized gain (loss) on available-for-sale securities and securitization assets (4,562)       (4,502) (60)
Unrealized gain (loss) on interest rate swaps 16,666       16,443 223
Issued shares of common stock (in shares)   1,663,000        
Issued shares of common stock 51,628 $ 17 51,611      
Equity-based compensation 8,281   1,091     7,190
Issuance (repurchase) of vested equity-based compensation shares (in shares)   13,000        
Issuance (repurchase) of vested equity-based compensation shares (308)   (308)      
Dividends and distributions $ (48,897)     (47,998)   (899)
Ending balance (in shares) at Jun. 30, 2024 115,151,661 115,152,000        
Ending balance at Jun. 30, 2024 $ 2,323,167 $ 1,152 $ 2,467,512 $ (249,277) $ 41,052 $ 62,728